FDA Webview
X
about-us-banner

Articles

Home /Articles / FDA Federal Register Notices

Case Study in Corruption: Jeff Shuren’s CDRH

10/03/2023

“Power tends to corrupt and absolute power corrupts absolutely.” (Lord Acton in 1887) [Analysis by Jim Dickinson] Supp...

FDA Renews, Expands Certara Software

10/13/2020

FDA has renewed and expanded its licenses of Certara’s biosimulation software with more than 400 user licenses of the compan...

FDA Labeling Policies Blamed for IUD Damage to Women

09/22/2020

[Report by Jim Dickinson] Years of complaints about the adequacy of CDRH device labeling requirements are echoed in a new raft of ...

Guidance on Tobacco Products Document Submission

09/09/2016

Federal Register Notice: FDA is making available a revised draft guidance for industry entitled Health Document Submission Require...

Guidance on Planning/Design of Multi-Regional Trials

09/09/2016

Federal Register Notice: FDA is making available a draft guidance entitled E17 General Principles for Planning and Design of Multi...

Blood Products Panel to Meet

09/09/2016

Federal Register Notice: FDA will hold a meeting of the Blood Products Advisory Committee 11/17 from 8 a.m. to 5:30 p.m. and 11/18...

Board to Center for Toxicological Research to Meet

09/09/2016

Federal Register Notice: FDA will hold a meeting of the Science Advisory Board to the National Center for Toxicological Research (...

FDA Removes Civil Money Penalties Info from Regs

09/09/2016

Federal Register Final rule: FDA is amending 21 CFR 17.2 to remove the maximum civil money penalties table associated with statuto...

Info On Postmarket Surveillance Sent to OMB

09/08/2016

Federal Register Notice: FDA’s proposed collection of information “Postmarket Surveillance — 21 CFR Part 822,&rd...

Comments Sought on Device Recordkeeping Requirements

09/08/2016

Federal Register Notice: FDA seeks comments on recordkeeping requirements related to the medical devices current good manufacturin...